Shares of the Peter Thiel-backed psychedelic start-up Atai Life Sciences jumped Friday on its first day of trading on Wall Street.The newly listed Nasdaq stock opened up 40% before pulling back some.The German biotech's initial public offering was priced Thursday night at $15 per share, the high end of the expected range. The company, which